UnitedHealth subsidiary Change Healthcare down for a fourth day following cyberattack

UnitedHealth subsidiary Change Healthcare down for a fourth day following cyberattack


UnitedHealth Group Inc. headquarters stands in Minnetonka, Minnesota, U.S.

Mike Bradley | Bloomberg | Getty Images

Change Healthcare’s systems are down for a fourth straight day after parent company UnitedHealth Group disclosed that a suspected cybersecurity threat actor gained access to part of its information technology network on Wednesday. 

UnitedHealth, the biggest health-care company in the U.S. by market cap, owns the health-care provider Optum, which merged with Change Healthcare in 2022. Optum services more than 100 million patients in the U.S., according to its website, and Change Healthcare offers solutions for payment and revenue cycle management. 

UnitedHealth said it identified a “suspected nation-state-associated” actor behind the attack, according to a filing with the U.S. Securities and Exchange Commission on Thursday. The company isolated and disconnected the impacted systems “immediately upon detection” of the threat, the filing said. UnitedHealth did not share any more details about the nature of the attack in the filing.

In an update at around 2 p.m. ET Saturday, Change Healthcare said the disruption is expected to continue “at least” through the day. The company said Friday that it has a high level of confidence that Optum, UnitedHealthcare and UnitedHealth systems have not been impacted. 

“We are working on multiple approaches to restore the impacted environment and will not take any shortcuts or take any additional risk as we bring our systems back online,” Change Healthcare said Saturday. 

UnitedHealth did not share any additional information with CNBC beyond the update. 

While UnitedHealth did not specify exactly which Change Healthcare systems were impacted by the attack in its regulatory filing, companies like CVS Health said the interruption is impacting some of its business operations. 

CVS Health is continuing to fill prescriptions, but it is not able to process insurance claims in certain cases, the company told CNBC in a statement on Saturday. CVS Health said there is “no indication” that its own systems have been compromised.

“We’re committed to ensuring access to care as we navigate through this interruption,” CVS Health said in the statement. 

The American Hospital Association released a statement Thursday urging health-care organizations to disconnect from Optum until it is deemed safe to reconnect. The AHA said it has been talking with the Department of Health and Human Services, the FBI and the Cybersecurity and Infrastructure Security Agency about the attack, according to the statement.

The AHA declined to comment on the Change Healthcare cyberattack. The FBI, HHS and CISA did not return CNBC’s requests for comment. 



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More